Finance

Lists
Q2 2026 earnings • in 2 days
See details
REF:NYSE
Reformation Inc.
$13.72
+0.22%
(+0.030) 1D
Sep 8, 12:08:13 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REF...
Open
$13.96
High
$13.96
Low
$13.12
Mkt. cap
810.53M
Avg. vol.
595.11K
Volume
77.99K
52-wk high
$17.26
52-wk low
$12.83
No. of employees
1K
Open
$13.96
High
$13.96
Low
$13.12
Mkt. cap
810.53M
Avg. vol.
595.11K
Volume
77.99K
52-wk high
$17.26
52-wk low
$12.83
No. of employees
1K
About Reformation Inc.
CEO-
Employees1.26K
Founded2009
Headquarters-
SectorConsumer
Websitethereformation.com
Analyst ratings
Based on 9 analysts giving stock ratings to REF in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for REF in the last 3 months.
Highest
Current $13.72
$21.00 (+53.06%)
Average
$19.25 (+40.31%)
Lowest
$16.00 (+16.62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Irene Nattel
RBC Capital
Buy
Reiterated
$18.00
+31.2%
08/31/2026
Dylan Carden
William Blair
Buy
Maintained
-
-
08/29/2026
Dana Telsey
Telsey Advisory
Buy
Maintained
$20.00
+45.8%
08/28/2026
Simeon Siegel
Guggenheim
Buy
Initiated
$20.00
+45.8%
08/24/2026
Janine Stichter
BTIG
Buy
Initiated
$20.00
+45.8%
08/24/2026
Paul Lejuez
Citi
Buy
Initiated
$20.00
+45.8%
08/25/2026
Alexandra Straton
Morgan Stanley
Hold
Initiated
$16.00
+16.6%
08/24/2026
Mark Altschwager
Robert W. Baird
Buy
Initiated
$19.00
+38.5%
08/24/2026
Unknown Analyst
RBC Capital
Buy
Initiated
$18.00
+31.2%
08/24/2026
Matthew Boss
J.P. Morgan
Buy
Initiated
$21.00
+53.1%
08/24/2026
Next call in 2 days
Thu, Sep 10, 5:00 PM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / $0.22
Revenue / Est. (USD)
- / 154.43M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
86.09M
112.30M
Cost of goods sold
34.21M
33.30M
Cost of revenue
34.21M
33.30M
Research and development expenses
-
-
Total research and development expenses
-
-
Selling, general, and admin expenses
55.58M
91.39M
Operating expense
55.58M
91.39M
Total operating expenses
89.80M
124.69M
Operating income
-3.71M
-12.39M
Other non operating income
-73.00K
-255.00K
EBT including unusual items
-7.48M
-16.05M
EBT excluding unusual items
-7.28M
-15.60M
Income tax expense
-1.93M
-3.90M
Effective tax rate
25.76%
24.33%
Other operating expenses
-
-
Net income
-5.55M
-12.15M
Net profit margin
-6.45%
-10.82%
Earnings per share
-
-
Interest and investment income
655.00K
313.00K
Interest expense
-4.15M
-3.27M
Net interest expenses
-3.50M
-2.96M
Depreciation and amortization charges
-
-
EBITDA
-846.00K
-8.23M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps